Filter by tags: Clinical trial Calcium Clear all tag filters
2 news articles found
The Australian Nuclear Science and Technology Organisation (Ansto) said a new radioactive variation of the element scandium, scandium-47, had been produced in the OPAL reactor.
- Source: NEI Magazine
- Date: Tuesday, 24 March 2020
- Original article: neimagazine.com/news/newsansto-develops-produces-scandium-47-for-the-first-time-7833921
A new radioactive version of the element scandium has been produced in Australia's OPAL reactor for the first time. Scandium-47 has the potential for theranostic use, that is, both as a therapeutic drug and a diagnostic agent, and has similar properties to lutetium-177, which is already being used in clinical trials.
- Source: World Nuclear News
- Date: Friday, 20 March 2020
- Original article: world-nuclear-news.org/Articles/Australia-produces-first-batch-of-medical-isotope